{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:34:40Z","timestamp":1791974080291,"version":"4.4.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Women with uterine fibroids (UF) may undergo less invasive procedures than hysterectomy, including myomectomy, endometrial ablation (EA), and uterine artery embolization (UAE); however, long-term need for reintervention is not well characterized. We estimated reintervention rates for 5 years and identified predictors of reintervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      A longitudinal retrospective cohort study was conducted in women in MarketScan\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Commercial Claims and Encounters (Truven Health Analytics) aged 18\u201349 years with UF diagnosis before myomectomy, EA, or UAE from 2008 to 2014. Patients were categorized by initial procedure (index date) and required to have \u226512 months of continuous coverage before and after. Kaplan\u2013Meier analyses and Cox proportional hazard models were used to estimate survival without reintervention and hazard of reintervention for 5 years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study included 35,631 women with myomectomy (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200913,804: 8,018 abdominal, 941 hysteroscopic, and 4,845 laparoscopic), EA (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200917,198), and UAE (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20094,629). Myomectomy had the lowest 12-month reintervention rate (4.2%), followed by UAE (7.0%), then EA (12.4%; both\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001 relative of myomectomy). Estimates of 5-year reintervention rates were 19% for myomectomy (17%, 28%, and 20% for abdominal, hysteroscopic, and laparoscopic, respectively), 33% for EA, and 24% for UAE. EA and UAE had adjusted hazard ratios of 2.63 (95% confidence interval [CI], 2.44\u20132.83) and 1.56 (95% CI, 1.42\u20131.72). Prior anemia, bleeding, pelvic inflammatory disease, and abdominal and pelvic pain increased the hazard of reintervention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Reintervention rate estimates ranged from 17% to 33% for 5 years after myomectomy, EA, and UAE for patients with UF. Risk of requiring reintervention should be considered during treatment selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2017.6752","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T15:15:11Z","timestamp":1533654911000},"page":"1204-1214","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":54,"title":["Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids"],"prefix":"10.1177","volume":"27","author":[{"given":"Matthew R.","family":"Davis","sequence":"first","affiliation":[{"name":"Medicus Economics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Soliman","sequence":"additional","affiliation":[{"name":"AbbVie, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Castelli-Haley","sequence":"additional","affiliation":[{"name":"AbbVie, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Snabes","sequence":"additional","affiliation":[{"name":"AbbVie, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Surrey","sequence":"additional","affiliation":[{"name":"Colorado Center for Reproductive Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.99"},{"key":"e_1_3_3_3_2","first-page":"431","article-title":"Self-reported heavy bleeding associated with uterine leiomyomata","volume":"101","author":"Wegienka G","year":"2003","unstructured":"Wegienka G, , Baird DD, , Hertz-Picciotto I, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol, 2003; 101:431\u2013437.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_3_4_2","first-page":"483","article-title":"Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis","volume":"41","author":"Kjerulff KH","year":"1996","unstructured":"Kjerulff KH, , Langenberg P, , Seidman JD, , Stolley PD, , Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med, 1996; 41:483\u2013490.","journal-title":"J Reprod Med"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2008.0456"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318183fbab"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2011.09.005"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001160"},{"key":"e_1_3_3_9_2","first-page":"31","article-title":"Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease A Report on the Priority-Setting Process, Preliminary Data Analysis, and Research Plan","author":"Gliklich RE","year":"2011","unstructured":"Gliklich RE, , Leavy MB, , Velentgas P, , Campion DM, , Mohr P. Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease A Report on the Priority-Setting Process, Preliminary Data Analysis, and Research Plan. AHRQ Effective Health Care Program Research Reports, 2011; 31.","journal-title":"AHRQ Effective Health Care Program Research Reports"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.01.049"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.02952.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-012-0485-y"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2007.01526.x"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.00885.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000296526.71749.c9"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2006.15.1046"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31818c1766"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12319"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2010.03.012"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.08.034"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.03.1447"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002331"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30338-8"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2009.03.009"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.12.2663"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-3804(98)80025-X"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.11.075"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.03.019"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1069738"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/2050-5736-2-7"},{"key":"e_1_3_3_31_2","unstructured":"Hansen LC S. Health research data for the real world: The MarketScan Databases. White Paper. 2012. Available at: http:\/\/truvenhealth.com\/portals\/0\/assets\/PH_11238_0612_TEMP_MarketScan_WP_FINAL.pdf Accessed July27 2018."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2016.1159189"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062003"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2217\/CER.14.32"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-011-0228-5"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-468"},{"key":"e_1_3_3_38_2","first-page":"CD004638","article-title":"Minimally invasive surgical techniques versus open myomectomy for uterine fibroids","author":"Bhave Chittawar P","year":"2014","unstructured":"Bhave Chittawar P, , Franik S, , Pouwer AW, , Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev, 2014:CD004638.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.4.770"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgyn.2011.01.003"},{"key":"e_1_3_3_41_2","first-page":"864","article-title":"Comparison of long-term outcomes of myomectomy and uterine artery embolization","volume":"100","author":"Broder MS","year":"2002","unstructured":"Broder MS, , Goodwin S, , Chen G, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol, 2002; 100:864\u2013868.","journal-title":"Obstet Gynecol"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2017.6752","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2017.6752","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2017.6752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:47:46Z","timestamp":1777657666000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2017.6752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1089\/jwh.2017.6752"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2017.6752","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}